Justin J. McAnear, Chief Financial Officer at 10x Genomics, Inc. (TXG), sold 16,300 shares at $142.80 ($2.3M) on 2021-10-01, disclosed to the SEC on 2021-10-05.
Open-market sale of $2.3M TXG by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $141.96 | 634 | $90K | 3.8% |
| 2 | $141.96 | 634 | $90K | 3.8% |
| 3 | $142.80 | 2,500 | $357K | 15.3% |
| 4 | $143.79 | 5,666 | $815K | 34.8% |
| 5 | $143.79 | 5,666 | $815K | 34.8% |
| 6 | $144.57 | 1,200 |
| $173K |
| 7.4% |
| Total | $143.55 avg | 16,300 | $2.3M | 100% |
| Filing → |
| TXG | SELL | 2024-02-26 | $173K | — | Filing → |
| TXG | SELL | 2023-11-27 | $146K | — | Filing → |
| TXG | SELL | 2023-08-24 | $154K | — | Filing → |